Want to see JP:7782 full AI Analyst Report?
7782 Stock Chart & Stats
¥506.00
-¥3.00(-0.63%)
At close: 4:00 PM EST
¥506.00
-¥3.00(-0.63%)
Day’s Range― - ―
52-Week Range¥420.00 - ¥612.00
Previous CloseN/A
Volume6.40K
Average Volume (3M)8.77K
Market Cap
¥2.98B
Enterprise Value¥3.18B
Total Cash (Recent Filing)¥1.65B
Total Debt (Recent Filing)¥1.78B
Price to Earnings (P/E)12.6
Beta-0.09
Next Earnings
Aug 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.62%
Share Statistics
EPS (TTM)37.41
Shares Outstanding6,862,200
10 Day Avg. Volume14,810
30 Day Avg. Volume8,766
Financial Highlights & Ratios
PEG Ratio-0.91
Price to Book (P/B)1.17
Price to Sales (P/S)0.44
P/FCF Ratio9.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthConsistent multi-year top-line growth (9.7% then 6.5%) indicates durable demand for the company's medical instruments. That trend supports capacity utilization, incremental operating leverage and continued investment in product development, helping sustain long-term revenue momentum.
Material Free Cash Flow ImprovementA sharp improvement in free cash flow and close tracking with net income reflects higher earnings quality and genuine cash generation. Strong FCF supports dividend payments, reinvestment, and debt reduction, providing durable financial flexibility for strategic initiatives over multiple quarters.
Improving Balance Sheet MetricsReduced leverage and rising equity bolster balance-sheet resilience, lowering refinancing and solvency risk. This structural improvement increases capacity for targeted M&A or capex, and provides a steadier financial foundation to weather industry cycles over the next several quarters.
Bears Say
Margin Pressure / Profit DipEarnings declined even as revenue rose, signaling margin compression possibly from cost or mix shifts. Thin mid-single-digit net margins leave less buffer against input cost inflation or pricing pressure, constraining reinvestment and long-term return-on-capital unless margins recover.
Elevated Total Debt Vs. Earlier YearsWhile leverage improved year-over-year, the company still carries meaningful debt compared with pre-step-up periods. Elevated debt can raise interest expense sensitivity and limit strategic flexibility, increasing vulnerability to slower cash flow or higher rates over the medium term.
Operating Cash Flow VolatilityA decline in operating cash flow despite positive FCF points to working-capital or conversion variability. Persistent OCF swings can undermine funding predictability for capex, dividends and debt paydown, creating execution risk across multiple reporting periods if not stabilized.
7782 FAQ
What was Sincere Co. LTD.’s price range in the past 12 months?
Sincere Co. LTD. lowest stock price was ¥420.00 and its highest was ¥612.00 in the past 12 months.
What is Sincere Co. LTD.’s market cap?
Sincere Co. LTD.’s market cap is ¥2.98B.
When is Sincere Co. LTD.’s upcoming earnings report date?
Sincere Co. LTD.’s upcoming earnings report date is Aug 14, 2026 which is in 16 days.
How were Sincere Co. LTD.’s earnings last quarter?
Sincere Co. LTD. released its earnings results on May 15, 2026. The company reported ¥10.48 earnings per share for the quarter, beating the consensus estimate of N/A by ¥10.48.
Is Sincere Co. LTD. overvalued?
According to Wall Street analysts Sincere Co. LTD.’s price is currently Overvalued.
Does Sincere Co. LTD. pay dividends?
Sincere Co. LTD. pays a Annually dividend of ¥18 which represents an annual dividend yield of 3.62%. See more information on Sincere Co. LTD. dividends here
What is Sincere Co. LTD.’s EPS estimate?
Sincere Co. LTD.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sincere Co. LTD. have?
Sincere Co. LTD. has 6,862,200 shares outstanding.
What happened to Sincere Co. LTD.’s price movement after its last earnings report?
Sincere Co. LTD. reported an EPS of ¥10.48 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.232%.
Which hedge fund is a major shareholder of Sincere Co. LTD.?
Currently, no hedge funds are holding shares in JP:7782
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sincere Co. LTD.
Sincere Co., LTD. manufacture and sells contact lenses in Japan. It operates through three segments: Contact Lens, Consulting, and System business. The company also engages in consulting on medical hair removal clinic management, as well as the design, development, sale, and maintenance of package systems for the reuse industry. In addition, it provides management support for medical institutions, medical related businesses, and elderly facility management. The company was incorporated in 2008 and is headquartered in Tokyo, Japan.
Technical Analysis
HOYA
―
JINS HOLDINGS
―
Menicon Co
―
Japan Eyewear Holdings Co.,Ltd.
―
Seed Co., Ltd.
―